Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05743283 · ClinicalTrials.gov registry record · NA

Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds

A NA study of Wound Heal, sponsored by Synedgen.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT05743283 is a NA study of Wound Heal that is actively recruiting participants, run by Synedgen. The registered enrollment target is 100 participants, below the 115-participant average among 23 other Wound Heal trials with a reported enrollment target (13% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05743283, a NA study of Wound Heal, is actively recruiting participants, sponsored by Synedgen.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete brief surveys about their healing and well-being related to the wound healing.

Conditions Studied

Interventions

  • OTHER Saline
  • DEVICE SynEx Wound Cleanser

Study Locations (2)

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Missouri

  • Barnes Jewish Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-04-12
Est. Completion 2025-09
Phase NA

Sponsor

Synedgen

2 total trials

What the Registry Record Tells You About NCT05743283

The ClinicalTrials.gov registry entry for NCT05743283 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 115-participant average among 23 other Wound Heal trials with a reported enrollment target (13% lower). The listed sponsor is Synedgen, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Wound Heal appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT05743283 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Missouri.

Frequently Asked Questions

What is clinical trial NCT05743283 about?

NCT05743283 is a clinical study titled "Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds". The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete ...

What is the current status of trial NCT05743283?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-12. Estimated completion is 2025-09.

What conditions does trial NCT05743283 study?

This clinical trial studies the following conditions: Wound Heal.

What interventions are being tested in trial NCT05743283?

The interventions under investigation include: Saline (OTHER), SynEx Wound Cleanser (DEVICE).

Who is sponsoring clinical trial NCT05743283?

This trial is sponsored by Synedgen, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05743283 being conducted?

This trial has 2 study locations across District of Columbia, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wound Heal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.